Odrinol

Disodium Phosphate Dodecahydrate, the active ingredient in Odrinol, is a mineral salt presented as an oral formulation for systemic use. It is used to correct electrolyte imbalances and support metabolic functions in clinical settings.

GNH USA supplies Odrinol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Odrinol is employed in medical practice to manage conditions related to phosphate balance and metabolic regulation: - Hypophosphatemia: helps restore normal serum phosphate levels. - Metabolic acidosis associated with renal failure: contributes to buffering capacity. - Preparation for certain diagnostic imaging procedures that require phosphate loading. - Adjunctive therapy during renal replacement therapy to maintain electrolyte homeostasis. - Supportive care in intensive care units for patients with severe electrolyte disturbances.

Phosphate salts are generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Nausea: mild gastrointestinal discomfort. - Vomiting: occasional expulsion of stomach contents. - Diarrhea: loose stools may develop. - Abdominal pain: cramping or discomfort in the stomach area. - Hyperphosphatemia: elevated serum phosphate if overdosed.

Serious or Rare Side Effects: - Hypocalcemia: low calcium levels secondary to phosphate binding. - Metabolic alkalosis: shift in acid‑base balance. - Allergic reaction: rash, itching, or swelling. - Renal impairment worsening: excess phosphate load may stress kidneys. - Severe electrolyte disturbances: potentially life‑threatening imbalances.

When using Odrinol, consider the following safety measures: - Dose adjustment: tailor dosing for patients with renal insufficiency. - Monitor electrolytes: regularly check serum phosphate, calcium, and magnesium. - Fluid balance: assess patient hydration status to avoid overload. - Concomitant medications: review other phosphate‑containing products. - Pregnancy and lactation: use only if clearly needed; limited data are available. - Store at below 25°C: keep in the original container, protect from moisture and direct sunlight.

Phosphate salts can interact with several medicines, altering absorption or electrolyte balance.

Major Interactions (Avoid): - Calcium supplements: may precipitate calcium phosphate and reduce absorption. - Iron salts: can form insoluble complexes, decreasing bioavailability.

Moderate Interactions (Monitor Closely): - Bisphosphonates: concurrent use may affect phosphate homeostasis. - Antacids containing aluminum or magnesium: may interfere with phosphate uptake. - Loop diuretics: increase renal phosphate loss, requiring closer monitoring. - Vitamin D analogues: influence calcium‑phosphate metabolism. - Certain antibiotics (e.g., tetracyclines): may chelate with phosphate.